title: Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
authors.affiliation: Micromyx, LLC, Kalamazoo, MI, USA.
authors.forename: Debora
authors.initials: D
authors.lastname: Sweeney
authors.affiliation: Micromyx, LLC, Kalamazoo, MI, USA.
authors.forename: Audrey
authors.initials: A
authors.lastname: Stoneburner
authors.affiliation: Micromyx, LLC, Kalamazoo, MI, USA.
authors.forename: Dean L
authors.initials: DL
authors.lastname: Shinabarger
authors.affiliation: The Medicines Company, Ville Saint Laurent, Québec, Canada.
authors.forename: Francis F
authors.initials: FF
authors.lastname: Arhin
authors.affiliation: The Medicines Company, Ville Saint Laurent, Québec, Canada.
authors.forename: Adam
authors.initials: A
authors.lastname: Belley
authors.affiliation: The Medicines Company, Ville Saint Laurent, Québec, Canada.
authors.forename: Greg
authors.initials: G
authors.lastname: Moeck
authors.affiliation: Micromyx, LLC, Kalamazoo, MI, USA cpillar@micromyx.com.
authors.forename: Chris M
authors.initials: CM
authors.lastname: Pillar
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000382:microbiology; D016983:Enterococcus / Q000187:drug effects* / Q000302:isolation & purification; D013293:Enterococcus faecalis / Q000187:drug effects; D006020:Glycopeptides / Q000494:pharmacology*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006801:Humans; D000077427:Lipoglycopeptides; D008826:Microbial Sensitivity Tests / Q000379:methods; D014640:Vancomycin / Q000494:pharmacology / Q000031:analogs & derivatives; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D000077427:Lipoglycopeptides; D014640:Vancomycin; C100708:oritavancin